XK
ALNY icon

Xact Kapitalforvaltning’s Alnylam Pharmaceuticals ALNY Stock Holding History

Xact Kapitalforvaltning’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1.95M Hold
17,900
– – 0.04% 346
2019
Q4 		$2.06M Hold
17,900
– – 0.04% 404
2019
Q3 		$1.44M Buy
17,900
+2,500
+16% +$198K 0.03% 463
2019
Q2 		$1.12M Sell
15,400
-7,700
-33% -$591K 0.02% 541
2019
Q1 		$2.16M Buy
23,100
+6,347
+38% +$531K 0.05% 351
2018
Q4 		$1.22M Buy
16,753
+1,608
+11% +$124K 0.03% 478
2018
Q3 		$1.32M Sell
15,145
-784
-5% -$78.9K 0.03% 513
2018
Q2 		$1.57M Buy
15,929
+486
+3% +$48.2K 0.03% 477
2018
Q1 		$1.84M Buy
15,443
+1,122
+8% +$145K 0.04% 418
2017
Q4 		$1.82M Buy
+14,321
New +$1.8M 0.04% 414
2016
Q4 		– Sell
-6,885
Closed -$467K – 640
2016
Q3 		$467K Buy
+6,885
New +$486K 0.02% 586

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Xact Kapitalforvaltning's ALNY Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Alnylam Pharmaceuticals (ALNY) position steady in Q1 2020 at 17,900 shares worth $1.95M. The position accounts for 0.04% of the portfolio, ranked #346.

Xact Kapitalforvaltning first reported a position in ALNY in Q3 2016 and has held it in 11 quarters since. The position peaked at $2.16M in Q1 2019. 331 funds tracked by Wall St. Rank hold ALNY as of Q1 2020.

  • Xact Kapitalforvaltning held 17,900 shares of Alnylam Pharmaceuticals worth $1.95M as of Q1 2020.
  • Xact Kapitalforvaltning left its Alnylam Pharmaceuticals share count unchanged in Q1 2020.
  • Alnylam Pharmaceuticals made up 0.04% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #346 holding.
  • Xact Kapitalforvaltning first reported a position in Alnylam Pharmaceuticals in Q3 2016 and has held it in 11 quarters since.
  • Xact Kapitalforvaltning's Alnylam Pharmaceuticals position peaked at $2.16M in Q1 2019.
  • 331 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.